Dr Shuxing Yin

Senior Lecturer in Finance

Room: C064
Phone: +44 (0)114 222 3344
Email: shuxing.yin@sheffield.ac.uk
Shuxing_Yin

Shuxing holds a BSc in Finance from Sichuan University (China), a MSc in International Securities and Investment Banking from University of Reading, and a PhD from the University of Manchester. Before joining the School of Management in February 2009, she worked as Senior Lecturer in Finance at University of Hertfordshire. Her previous work experience also includes employment in the Investment Banking Division for Western Securities Company in China.

Teaching

Shuxing is the module leader of a third year undergraduate finance module:

MGT 321 Corporate Finance

The course covers more advanced topics in corporate finance, such as financing and investment decisions under asymmetric information, valuation techniques for investment appraisal such as real option pricing. Equity financing, hybrid financing, and mergers & acquisitions are discussed. The efficient market hypothesis is challenged and an alternative approach to finance, behavioural finance, is reviewed.

She is also the module leader of a core module in the MSc Accounting and Finance:

MGT 6097 Corporate Finance

The purpose of the course is to give a solid foundation in principles of corporate finance and asset pricing to understand and analyse the major issues affecting the financial policies of corporations. More specifically, the following topics will be dealt with: the time value of money, valuation of bond and equity, capital budgeting techniques, risk/return tradeoffs, portfolio theory, capital structure, payout policy, sources of financing and market efficiency.

Research

Shuxing's research interests include corporate finance, corporate governance, market efficiency and anomalies. She has acted as referee for Journal of Corporate Finance, Journal of International Financial Markets, Institutions and Money, British Accounting Review, European Journal of Finance.

She welcomes PhD applicants in the field of corporate finance, particularly focusing on Chinese (mainland and Hong Kong) markets, initial public offerings and market efficiency.